Impacts of invasive species are often difficult to quantify, meaning that many invaders are prioritised for management without robust, contextual evidence of impact. Most impact studies for invasive plants compare heavily invaded with non-invaded sites, revealing little about abundance-impact relationships. We examined effects of increasing cover and volume of the non-native herbaceous groundcover Tradescantia fluminensis on a temperate rainforest community of southern Australia. We hypothesised that there would be critical thresholds in T. fluminensis abundance, below which the native plant community would not be significantly impacted, but above which the community's condition would degrade markedly. We modelled the abundance-impact relationship from 83 plots that varied in T. fluminensis abundance and landscape context and found the responses of almost all native plant indicators to invasion were non-linear. Native species richness, abundance and diversity exhibited negative exponential relationships with increasing T. fluminensis volume, but negative threshold relationships with increasing T. fluminensis cover. In the latter case, all metrics were relatively stable until cover reached between 20 and 30%, after which each decreased linearly, with a 50% decline occurring at 75-80% invader cover. Few growth forms (notably shrubs and climbers) exhibited such thresholds, with most exhibiting negative exponential relationships. Tradescantia fluminensis biomass increased dramatically at > 80% cover, with few native species able to persist at such high levels of invasion. Landscape context had almost no influence on native communities, or the abundance-impact relationships between T. fluminensis and the plant community metrics. Our results suggest that the diversity of native rainforest community can be maintained where T. fluminensis is present at moderate-to-low cover levels.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520009 | PMC |
http://dx.doi.org/10.1038/s41598-021-98667-5 | DOI Listing |
Background And Aim: The high rate of tumor growth results in an increased need for amino acids. As solute carriers (SLC) transporters are capable of transporting different amino acids, cancer may develop as a result of these transporters' over-expression due to their complex formation with other biological molecules. Therefore, this review investigated the role of SLC transporters in the progression of cancer.
View Article and Find Full Text PDFVet Res Forum
November 2024
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Docetaxel (DTX) is widely utilized in breast cancer treatment. However, cancer cell resistance has limited its anti-tumor efficacy. Some molecules called microRNAs (miRNAs), acting like fine-tuned switches, can influence how breast cancer develops and spreads.
View Article and Find Full Text PDFBMJ Open
December 2024
Centre for Surgical Research, University of Bristol, Bristol, UK.
Background: Surgical interventions are inherently complex and designing and conducting surgical randomised controlled trials (RCTs) can be challenging. Trial design impacts the applicability of trial results to clinical practice. Given the recent growth in numbers of surgical RCTs, there is a need to better understand the validity and applicability of trials in this field.
View Article and Find Full Text PDFBMJ Open
December 2024
Wiser Healthcare Research Collaboration, Sydney, New South Wales, Australia
Introduction: A diagnosis of melanoma in situ presents negligible risk to a person's lifespan or physical well-being, but existing terminology makes it difficult for patients to distinguish these from higher risk invasive melanomas. This study aims to explore whether using an alternative label for melanoma in situ may influence patients' management choices and anxiety levels.
Methods And Analysis: This study is a between-subjects randomised online experiment, using hypothetical scenarios.
J Hematol Oncol
January 2025
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.
The tumor microenvironment (TME) is integral to cancer progression, impacting metastasis and treatment response. It consists of diverse cell types, extracellular matrix components, and signaling molecules that interact to promote tumor growth and therapeutic resistance. Elucidating the intricate interactions between cancer cells and the TME is crucial in understanding cancer progression and therapeutic challenges.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!